264 related articles for article (PubMed ID: 22993535)
1. Dietary factors, genetic and epigenetic influences in colorectal cancer.
Pellegrini ML; Argibay P; Gomez DE
Exp Ther Med; 2010 Mar; 1(2):241-250. PubMed ID: 22993535
[TBL] [Abstract][Full Text] [Related]
2. [Genetics and epigenetics of colorectal cancer].
Pellegrini ML; Argibay P; Gómez DE
Acta Gastroenterol Latinoam; 2011 Sep; 41(3):247-61. PubMed ID: 22233005
[TBL] [Abstract][Full Text] [Related]
3. Unveiling the genetic and epigenetic landscape of colorectal cancer: new insights into pathogenic pathways.
Postwala H; Shah Y; Parekh PS; Chorawala MR
Med Oncol; 2023 Oct; 40(11):334. PubMed ID: 37855910
[TBL] [Abstract][Full Text] [Related]
4. Epigenetics and its therapeutic potential in colorectal cancer.
Oryani MA; Tavasoli A; Ghalavand MA; Ashtiani RZ; Rezaee A; Mahmoudi R; Golvari H; Owrangi S; Soleymani-Goloujeh M
Epigenomics; 2022 Jun; 14(11):683-697. PubMed ID: 35473313
[TBL] [Abstract][Full Text] [Related]
5. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas.
Cunningham JM; Kim CY; Christensen ER; Tester DJ; Parc Y; Burgart LJ; Halling KC; McDonnell SK; Schaid DJ; Walsh Vockley C; Kubly V; Nelson H; Michels VV; Thibodeau SN
Am J Hum Genet; 2001 Oct; 69(4):780-90. PubMed ID: 11524701
[TBL] [Abstract][Full Text] [Related]
6. The role of epigenetic therapies in colorectal cancer.
Baretti M; Azad NS
Curr Probl Cancer; 2018 Nov; 42(6):530-547. PubMed ID: 29625794
[TBL] [Abstract][Full Text] [Related]
7. On the road to colorectal cancer development: crosstalk between the gut microbiota, metabolic reprogramming, and epigenetic modifications.
Chen A; Jiang Z; Cai L; Tang D
Carcinogenesis; 2023 Dec; 44(8-9):631-641. PubMed ID: 37586059
[TBL] [Abstract][Full Text] [Related]
8. Genetic and epigenetic dependencies in colorectal cancer development.
Parmar S; Easwaran H
Gastroenterol Rep (Oxf); 2022; 10():goac035. PubMed ID: 35975243
[TBL] [Abstract][Full Text] [Related]
9. PIK3CA mutation and methylation influences the outcome of colorectal cancer.
Iida S; Kato S; Ishiguro M; Matsuyama T; Ishikawa T; Kobayashi H; Higuchi T; Uetake H; Enomoto M; Sugihara K
Oncol Lett; 2012 Mar; 3(3):565-570. PubMed ID: 22740953
[TBL] [Abstract][Full Text] [Related]
10. Diet and epigenetics in colon cancer.
Nystrom M; Mutanen M
World J Gastroenterol; 2009 Jan; 15(3):257-63. PubMed ID: 19140224
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Alteration in Colorectal Cancer: A Biomarker for Diagnostic and Therapeutic Application.
Essa HYS; Kusaf G; Yuruker O; Kalkan R
Glob Med Genet; 2022 Sep; 9(3):258-262. PubMed ID: 36188672
[TBL] [Abstract][Full Text] [Related]
12. Role of Microbiome in Carcinogenesis Process and Epigenetic Regulation of Colorectal Cancer.
Farhana L; Banerjee HN; Verma M; Majumdar APN
Methods Mol Biol; 2018; 1856():35-55. PubMed ID: 30178245
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.
Okugawa Y; Grady WM; Goel A
Gastroenterology; 2015 Oct; 149(5):1204-1225.e12. PubMed ID: 26216839
[TBL] [Abstract][Full Text] [Related]
14. Genetic Mutations and Non-Coding RNA-Based Epigenetic Alterations Mediating the Warburg Effect in Colorectal Carcinogenesis.
Abi Zamer B; Abumustafa W; Hamad M; Maghazachi AA; Muhammad JS
Biology (Basel); 2021 Aug; 10(9):. PubMed ID: 34571724
[TBL] [Abstract][Full Text] [Related]
15. Immunoassay for wild-type protein in lymphocytes predicts germline mutations in patients at risk for hereditary colorectal cancer.
Fields JZ; Gao Z; Gao Z; Lewis M; Maimonis P; Harvey J; Lynch HT; Boman BM
J Lab Clin Med; 2004 Jan; 143(1):59-66. PubMed ID: 14749686
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.
Cunningham JM; Christensen ER; Tester DJ; Kim CY; Roche PC; Burgart LJ; Thibodeau SN
Cancer Res; 1998 Aug; 58(15):3455-60. PubMed ID: 9699680
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic profiling of MUTYH, KLF6, WNT1 and KLF4 genes in carcinogenesis and tumorigenesis of colorectal cancer.
Babaei K; Khaksar R; Zeinali T; Hemmati H; Bandegi A; Samidoust P; Ashoobi MT; Hashemian H; Delpasand K; Talebinasab F; Naebi H; Mirpour SH; Keymoradzadeh A; Norollahi SE
Biomedicine (Taipei); 2019 Dec; 9(4):22. PubMed ID: 31724937
[TBL] [Abstract][Full Text] [Related]
18. Novel methylation gene panel in adjacent normal tissues predicts poor prognosis of colorectal cancer in Taiwan.
Hsu CH; Hsiao CW; Sun CA; Wu WC; Yang T; Hu JM; Huang CH; Liao YC; Chen CY; Lin FH; Chou YC
World J Gastroenterol; 2020 Jan; 26(2):154-167. PubMed ID: 31988582
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and hMSH2/hMLH1 germ-line mutations in Chinese patients with hereditary nonpolyposis colorectal cancer.
Shen XS; Zhao B; Wang ZJ
Chin Med J (Engl); 2008 Jul; 121(14):1265-8. PubMed ID: 18713544
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of tumor suppressor lncRNA MEF2C-AS1 frequently happened in patients at all stages of colorectal carcinogenesis.
Qian S; Lin S; Xu X; Bai H; Yeerken A; Ying X; Li Z; Fei X; Yang J; Tang M; Wang J; Jin M; Chen K
Clin Epigenetics; 2022 Sep; 14(1):111. PubMed ID: 36064442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
